RPRX Royalty Pharma plc
2026Q1 · CUSIP G7709Q104 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
584
Δ holders QoQ
+46
Breadth percentile
Top 5%
Whale holders
236
Δ whales
+18
Inst. holding value
$16.9B
New positions
114
Closed positions
68
Price momentum (1Q)
—
Put / Call
3/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 13 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 5% | — | — |
| 2025Q4 | Top 10% | — | — |
| 2025Q3 | Top 10% | — | — |
| 2025Q1 | Top 7% | — | — |
| 2024Q1 | Top 18% | — | — |
| 2023Q4 | Top 10% | — | — |
| 2022Q3 | Top 2% | — | — |
| 2022Q2 | Top 19% | — | — |
Options Sentiment
Put holders
3
QoQ: 0
Call holders
6
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
29.4
EPS (TTM)
$1.90
EPS YoY
-22.4%
Revenue (TTM)
$2.4B
Revenue YoY
+7.8%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)